Pharmabiz

Actinium Pharma to present new pan-tumour preclinical data for ATNM-400 in solid tumours and differentiated mechanism for Actimab-A in AML at 2026 AACR meeting

Actinium Pharma to present new pan-tumour preclinical data for ATNM-400 in solid tumours and differentiated mechanism for Actimab-A in AML at 2026 AACR meeting: New York Tuesday, ...
Pharmabiz

India’s healthcare & pharma sector to witness a 30–35% hiring uptick by 2030: Adecco India

India’s healthcare & pharma sector to witness a 30–35% hiring uptick by 2030: Adecco India: Our Bureau, Bengaluru Tuesday, April 7, 2026, 17:25 Hrs [IST] Adecco India has note ...
Pharmabiz

Lifestyle disease awareness deepens in Tier 2 cities, finds Practo

Lifestyle disease awareness deepens in Tier 2 cities, finds Practo: Our Bureau, Bengaluru Tuesday, April 7, 2026, 17:40 Hrs [IST] Practo, India’s healthcare platform, has shared ...
Pharmabiz

AstraZeneca India inks MoU with Telangana govt to bring AI-powered lung cancer screening to public hospitals

AstraZeneca India inks MoU with Telangana govt to bring AI-powered lung cancer screening to public hospitals: Our Bureau, Bengaluru Tuesday, April 7, 2026, 16:30 Hrs [IST] AstraZe ...
Pharmabiz

Siemens Healthineers deepens Make in India commitment with production of Artis One Edition X angiography systems

Siemens Healthineers deepens Make in India commitment with production of Artis One Edition X angiography systems: Our Bureau, Bengaluru Tuesday, April 7, 2026, 16:20 Hrs [IST] Sie ...
Pharmabiz

Affinia Therapeutics gets Health Canada approval to initiate UPBEAT phase 1/2 trial to investigate AFTX-201 to treat BAG3-associated DCM

Affinia Therapeutics gets Health Canada approval to initiate UPBEAT phase 1/2 trial to investigate AFTX-201 to treat BAG3-associated DCM: Waltham, Massachusetts Tuesday, April 7, ...
Pharmabiz

Profusa expands into molecular diagnostics through a LoI to acquire the PanOmics multi-omics diagnostics platform from BioInsights

Profusa expands into molecular diagnostics through a LoI to acquire the PanOmics multi-omics diagnostics platform from BioInsights: Berkeley, California Tuesday, April 7, 2026, 16 ...
Pharmabiz

Alembic Pharma receives US FDA final approval for dapagliflozin tablets, 5 mg and 10 mg

Alembic Pharma receives US FDA final approval for dapagliflozin tablets, 5 mg and 10 mg: Our Bureau, Mumbai Tuesday, April 7, 2026, 14:30 Hrs [IST] Alembic Pharmaceuticals Limited ...
Pharmabiz

MedGenome unveils study indicating clinical impact of RNA-based NGS in sarcoma diagnosis

MedGenome unveils study indicating clinical impact of RNA-based NGS in sarcoma diagnosis: Our Bureau, Bengaluru Tuesday, April 7, 2026, 15:45 Hrs [IST] MedGenome, India’s leadin ...
Pharmabiz

GC Biopharma enhances IVIG safety profile with advanced prothrombotic impurity detection technology

GC Biopharma enhances IVIG safety profile with advanced prothrombotic impurity detection technology: Yongin, South Korea Tuesday, April 7, 2026, 17:00 Hrs [IST] GC Biopharma, a gl ...
Pharmabiz

Buldhana marks 75-day countdown to International Day of Yoga with Asia world record

Buldhana marks 75-day countdown to International Day of Yoga with Asia world record: Our Bureau, Chennai Tuesday, April 7, 2026, 16:10 Hrs [IST] On the occasion of Yoga Mahotsav20 ...
Pharmabiz

NeuroSense’s proprietary PrimeC composition receives Brazilian patent

NeuroSense’s proprietary PrimeC composition receives Brazilian patent: Cambridge, Massachusetts Tuesday, April 7, 2026, 14:00 Hrs [IST] NeuroSense Therapeutics Ltd., a late-clin ...